Cerus Corporation to Participate in Upcoming Investor Conferences
03 Novembre 2023 - 1:30PM
Business Wire
Cerus Corporation (NASDAQ:CERS) announced today that the Company
will participate in two upcoming investor conferences:
- William “Obi” Greenman, Cerus’ president and chief executive
officer, is scheduled to participate in a fireside chat at The
Stifel 2023 Healthcare Conference on Tuesday, November 14th, at
4:10 p.m. EST, at the Lotte New York Palace Hotel. A live webcast
of the fireside chat will be available here. A replay will be
available after the event.
- Kevin Green, Cerus’ vice president and chief financial officer,
is scheduled to participate in a fireside chat at The Stephens
Annual Investment Conference on Wednesday, November 15th, at 1:00
p.m. EST, at the Grand Hyatt in Nashville, TN. A live webcast of
the fireside chat will be available here. A replay will be
available after the event.
ABOUT CERUS
Cerus Corporation is dedicated solely to safeguarding the
world’s blood supply and aims to become the preeminent global blood
products company. Headquartered in Concord, California, the company
develops and supplies vital technologies and pathogen-protected
blood components to blood centers, hospitals, and ultimately
patients who rely on safe blood. The INTERCEPT Blood System for
platelets and plasma is available globally and remains the only
pathogen reduction system with both CE mark and FDA approval for
these two blood components. The INTERCEPT red blood cell system is
under regulatory review in Europe, and in late-stage clinical
development in the US. Also in the US, the INTERCEPT Blood System
for Cryoprecipitation is approved for the production of Pathogen
Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to
as INTERCEPT Fibrinogen Complex), a therapeutic product for the
treatment and control of bleeding, including massive hemorrhage,
associated with fibrinogen deficiency. For more information about
Cerus, visit www.cerus.com and follow us on LinkedIn.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus
Corporation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231103690847/en/
Jessica Hanover – Vice President, Corporate Affairs Cerus
Corporation 925-288-6137
Grafico Azioni Cerus (NASDAQ:CERS)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Cerus (NASDAQ:CERS)
Storico
Da Mag 2023 a Mag 2024